We found a marginal difference in AB scoring between p53+/+;ErbB2, p53−/+;ErbB2 and p53H/+;ErbB2 mammary tumors, whereas the absence of wtp53 allele markedly increased AB in ErbB2 mammary tumors (Fig. 4c). Here, ERBB2 is linked to breast cancer.